Genotoxic Impurities in Drug Substances

被引：5
|
作者：
Snodin, David [1 ]
机构：
[1] PAREXEL Consulting, VP Nonclin, The Quays, Uxbridge UB8 1LZ, Middx, England
来源：
ORGANIC PROCESS RESEARCH & DEVELOPMENT | 2009年 / 13卷 / 03期
关键词：
D O I：
10.1021/op900043v
中图分类号：
O69 [应用化学];
学科分类号：
081704 ;
摘要：
引用
收藏
页码：409 / 409
页数：1
相关论文
共 50 条
  • [1] Genotoxic impurities in production batches of drug substances
    O'Donovan, Mike
    [J]. MUTAGENESIS, 2010, 25 (06) : 639 - 640
  • [2] Regulation of genotoxic and carcinogenic impurities in drug substances and products
    McGovern, Timothy
    Jacobson-Kram, David
    [J]. TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2006, 25 (08) : 790 - 795
  • [3] Recent developments in the risk assessment of potentially genotoxic impurities in pharmaceutical drug substances
    Humfrey, Charles D. N.
    [J]. TOXICOLOGICAL SCIENCES, 2007, 100 (01) : 24 - 28
  • [4] Regulatory Expectations Towards Genotoxic Impurities in Drug Substances: DMF and ASMF Perspective
    Raman, Nanduri V. V. S. S.
    Prasad, Adapa V. S. S.
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2014, 18 (07) : 834 - 835
  • [5] Approaches to Assessment, Testing Decisions, and Analytical Determination of Genotoxic Impurities in Drug Substances
    Pierson, Duane A.
    Olsen, Bernard A.
    Robbins, Avid K.
    DeVries, Keith M.
    Varie, David L.
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2009, 13 (02) : 285 - 291
  • [6] Strategies for the identification, control and determination of genotoxic impurities in drug substances: A pharmaceutical industry perspective
    Raman, N. V. V. S. S.
    Prasad, A. V. S. S.
    Reddy, K. Ratnakar
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2011, 55 (04) : 662 - 667
  • [7] Sensitive derivatization methods for the determination of genotoxic impurities in drug substances using hyphenated techniques
    Raman, Nanduri V. V. S. S.
    Prasad, Adapa V. S. S.
    Reddy, Kura Ratnakar
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 89 : 276 - 281
  • [8] In silico approaches to predicting cancer potency for risk assessment of genotoxic impurities in drug substances
    Bercu, Joel P.
    Morton, Stuart M.
    Deahl, J. Thom
    Gombar, Vijay K.
    Callis, Courtney M.
    van Lier, Robert B. L.
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2010, 57 (2-3) : 300 - 306
  • [9] Impurities in Oligonucleotide Drug Substances and Drug Products
    Capaldi, Daniel
    Teasdale, Andy
    Henry, Scott
    Akhtar, Nadim
    den Besten, Cathaline
    Gao-Sheridan, Samantha
    Kretschmer, Matthias
    Sharpe, Neal
    Andrews, Ben
    Burm, Brigitte
    Foy, Jeffrey
    [J]. NUCLEIC ACID THERAPEUTICS, 2017, 27 (06) : 309 - 322
  • [10] GENOTOXIC IMPURITIES
    Thayer, Ann M.
    [J]. CHEMICAL & ENGINEERING NEWS, 2010, 88 (39) : 16 - +
12345